Lin Wu
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Epidemiology top 10%
- Congenital Heart Disease Studies
Papers in
-
- Ferroptosis and cancer prognosis 3
- Coronary Artery Anomalies 3
- Vasculitis and related conditions 2
- Surgery 15
- Kawasaki Disease and Coronary Complications 6
- Co-authors
- Jun Ren (8 shared papers)Yingmei Zhang (5 shared papers)Qu‐ming Zhao (11 shared papers)Xiaojing Ma (9 shared papers)Litao Wang (5 shared papers)Yuxin Du (4 shared papers)Conway Niu (5 shared papers)Guoying Huang (5 shared papers)
- Journals
- Medicine (3 papers)Journal of Vascular and Interventional Radiology (2 papers)BMC Pediatrics (2 papers)PEDIATRICS (2 papers)Acta Pharmacologica Sinica (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin Wu
82 papers receiving 1.3k citations
Lin Wu's Hit Papers
Peers
Comparison fields: 5 of 98
- Cardiology and Cardiovascular Medicine 263
- Epidemiology 332
- Pulmonary and Respiratory Medicine 285
- Cancer Research 86
- Transplantation 13
Countries citing papers authored by Lin Wu
This map shows the geographic impact of Lin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Wu more than expected).
Fields of papers citing papers by Lin Wu
This network shows the impact of papers produced by Lin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Wu. The network helps show where Lin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity Hit paper breakdown → | 2022 | 171 |
| 2 | 2014 | 162 | |
| 3 | 2018 | 140 | |
| 4 | 2015 | 93 | |
| 5 | 2022 | 51 | |
| 6 | 2005 | 38 | |
| 7 | 2022 | 36 | |
| 8 | 2013 | 36 | |
| 9 | 2017 | 35 | |
| 10 | 2008 | 35 | |
| 11 | 2024 | 33 | |
| 12 | 2019 | 30 | |
| 13 | 2023 | 29 | |
| 14 | 2024 | 28 | |
| 15 | 2011 | 26 | |
| 16 | 2019 | 25 | |
| 17 | 2013 | 23 | |
| 18 | 2020 | 15 | |
| 19 | 2015 | 14 | |
| 20 | 2019 | 14 |
About Lin Wu
Lin Wu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Epidemiology, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 86 papers that have together received 1.3k indexed citations. Recurring topics across this work include Congenital Heart Disease Studies (10 papers), Kawasaki Disease and Coronary Complications (6 papers), Ferroptosis and cancer prognosis (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Coronary Artery Anomalies (3 papers), RNA modifications and cancer (3 papers), Vasculitis and related conditions (2 papers) and Cardiac Arrhythmias and Treatments (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (263 citations), Epidemiology (332 citations), Pulmonary and Respiratory Medicine (285 citations), Cancer Research (86 citations) and Transplantation (13 citations). Lin Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jun Ren, Yingmei Zhang, Qu‐ming Zhao, Xiaojing Ma, Litao Wang, Yuxin Du, Conway Niu, Guoying Huang, Guoying Huang and Fang Liu. Their work appears in journals such as Medicine, Journal of Vascular and Interventional Radiology, BMC Pediatrics, PEDIATRICS and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.